Syndax Pharmaceuticals Inc (NAS:SNDX)
$ 13.07 -0.24 (-1.8%) Market Cap: 1.12 Bil Enterprise Value: 710.08 Mil PE Ratio: 0 PB Ratio: 3.04 GF Score: 32/100

Q1 2019 Syndax Pharmaceuticals Inc Earnings Call Transcript

May 06, 2019 / 08:30PM GMT
Release Date Price: $7.36 (+2.79%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Syndax's First Quarter 2019 Financial Results Conference Call. (Operator Instructions) I would now like to turn the call over to your host, Ms. Melissa Forst with Argot Partners. Please go ahead.

Melissa Forst
Argot Partners, LLC - VP

Thank you, operator. Welcome and thank you to those of you joining us today for Syndax's First Quarter 2019 financial results conference call. Joining us this afternoon for prepared remarks will be Dr. Briggs Morrison, Chief Executive Officer; Michael Metzger, President and Chief Operating Officer; and Rick Shea, Chief Financial Officer. And also joining us on today's call for the question-and-answer session will be Dr. Michael Meyers, Chief Medical Officer; and Dr. Peter Ordentlich, Chief Scientific Officer. This call is being accompanied by a slide deck that has been posted on the company's website, so I would ask you to please turn to the forward-looking statements on Slide 2.

Before we begin, I would like to remind you that any statement made during this call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot